Table E4.
Gene | P value | Fold difference |
---|---|---|
Intradermal immunotherapy down vs control group | ||
LOC100133042 | .02 | −1.80 |
CEP55 | .03 | −1.78 |
GFOD1 | .00 | −1.77 |
HIST2H2AB | .04 | −1.62 |
H2AFZ | .02 | −1.61 |
LOC730534 | .01 | −1.57 |
HSD17B4 | .02 | −1.57 |
HIST1H2AD | .03 | −1.56 |
HDAC1 | .01 | −1.55 |
CCL3L1 | .03 | −1.53 |
CALR | .02 | −1.52 |
CDCA5 | .01 | −1.52 |
PRDX5 | .01 | −1.51 |
FEN1 | .02 | −1.50 |
Intradermal immunotherapy up vs control group | ||
EPS15 | .02 | 1.51 |
MYB | .01 | 1.52 |
GK | .03 | 1.53 |
RNASET2 | .03 | 1.55 |
LOC729383 | .02 | 1.56 |
GPR171 | .00 | 1.59 |
LOC729387 | .04 | 1.60 |
SLC11A2 | .02 | 1.60 |
HS.508682 | .04 | 1.68 |
IL5 | .03 | 1.71 |
GBP5 | .05 | 1.79 |
TNFSF8 | .01 | 1.79 |
TNIP3 | .03 | 1.87 |
CENTA1 | .05 | 2.11 |
Data were analyzed by using the 3 way-ANOVA model.